‹ Back to Intelligence
Infiniti Prediction Markets··By Infiniti Oracle

FDA approves Retatrutide this year priced at 3.2% on Polymarket, up 1.1 points, on $596K traded

FDA approves Retatrutide this year priced at 3.2% on Polymarket, up 1.1 points, on $596K traded

Infiniti Prediction Markets
FDA approves Retatrutide this year priced at 3.2% on Polymarket, up 1.1 points, on $596K traded
Retatrutide approval contract among traded tech markets.
#Health #PredictionMarkets #Polymarket

2 Fed rate hikes happen in 2026 priced at 80.0% on Polymarket, up 4.5 points, on $208K traded
Two-hikes contract among upward finance moves.
#Fed #PredictionMarkets #Polymarket

Iran-Oman Hormuz Agreement by December 31 priced at 29.5% on Polymarket, up 4.0 points, on $135K traded
Hormuz agreement contract among upward political moves.
#Geopolitics #PredictionMarkets #Polymarket

Markets: Gold 53% settled up (43.0M) | WTI 60% (8.7M) | BTC 48% (314.8M) | ETH 44% (21.2M)

web: Infiniti.w3ai.io
Infiniti Prediction Markets
https://infiniti.w3ai.io/infiniti-feed

Full attribution

Full attribution under the Digital Millennium Copyright Act (DMCA), 17 U.S.C. § 512: this article is an original report by Infiniti Intelligence that summarizes the reporting of the publishers named above, links to their original work, and reproduces no protected expression beyond brief factual reference and in-line attribution (“according to the publisher”). All rights in the underlying reporting remain with the publishers listed; nothing here implies endorsement by or affiliation with them. Rights holders may request correction, update or removal through the contact address published at infiniti.w3ai.io.